New Samsung TVs Will Support HDR10+ Advanced Streaming On Prime Video Starting This MonthAugust 4, 2026
Apnimed’s IPO Bags $192M for What Could Become the First Oral Sleep Apnea DrugNews DeskAugust 2, 20260 Apnimed, a sleep disorders drug developer whose lead therapeutic candidate is under FDA review, raised $192 million in a stock…
Startup to Acquisition in 2 Years: Grove AI’s Journey to Transform Clinical TrialsNews DeskJuly 31, 20260 Pharmaceutical companies often point to slow clinical trial enrollment as a chokepoint for drug development, but it’s no picnic for…
J&J Joins Immune Reset Race, Paying $785M to Partner on Sail Bio Cell TherapyNews DeskJuly 30, 20260 Johnson & Johnson, which was part of the wave of the first cell therapies, is now getting a next-generation contender…